# Amlodipine Plus Botulinum Toxin for Focal Dystonia

> **NCT00015457** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 16 (actual)

## Conditions studied

- Focal Dystonia

## Interventions

- **DRUG:** Amlodipine plus Botulinum toxin

## Key facts

- **NCT ID:** NCT00015457
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2009-04
- **Final completion:** —
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00015457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00015457, "Amlodipine Plus Botulinum Toxin for Focal Dystonia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00015457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*